Nancy Ryan Gray, a director at Ligand Pharmaceuticals ($LGND), sold shares on the open market twice in the last year, totaling $1.35 million. Her most recent sale occurred on November 7, 2025. These sales rank her 4,260th among 11,678 insiders by value sold, below the average of $8.6 million across about 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | M | Non-Qualified Stock Option (right to buy) | 3015 | $0.00 | 0.0000 | 20,629,000 | 100.00% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | M | Common Stock | 3556 | $66.19 | 11,650.0000 | 20,629,000 | 43.93% | 0.02% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | S | Common Stock | 3556 | $205.45 | 8,094.0000 | 20,629,000 | 30.52% | 0.02% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | M | Common Stock | 3015 | $73.57 | 11,109.0000 | 20,629,000 | 37.25% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | S | Common Stock | 3015 | $205.45 | 8,094.0000 | 20,629,000 | 27.14% | 0.01% |
| Nov. 7, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | M | Non-Qualified Stock Option (right to buy) | 3556 | $0.00 | 0.0000 | 20,629,000 | 100.00% | 0.02% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | A | Non-Qualified Stock Option (right to buy) | 5783 | $0.00 | 5,783.0000 | 18,290,000 | 9999.99% | 0.03% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | A | Common Stock | 1209 | $0.00 | 8,094.0000 | 18,290,000 | 17.56% | 0.01% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | A | Common Stock | 1252 | $0.00 | 6,885.0000 | 17,757,000 | 22.23% | 0.01% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | A | Non-Qualified Stock Option (right to buy) | 5444 | $0.00 | 5,444.0000 | 17,757,000 | 9999.99% | 0.03% |
| May 9, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Gray Nancy Ryan | Director | S | Common Stock | 934 | $83.20 | 5,633.0000 | 17,757,000 | 14.22% | 0.01% |